Short – NEWS

Sebi will release a ‘consultation paper’ next week to simplify becoming a registered investment advisor, a senior official announced on Friday. This move aims to tackle unregulated fin-influencers. The Sebi board recently approved measures to monitor fin-influencers, mainly through their ties with Sebi-regulated entities. Sebi plans to relax registration requirements for investment advisors and research … Read more

More than 100 countries, including India, face significant hurdles to becoming high-income nations, per the World Bank’s World Development Report 2024. India may take nearly 75 years to reach one-quarter of US income per capita. China might take over 10 years, and Indonesia nearly 70 years. The report notes many middle-income countries get stuck at … Read more

Delhivery posted a profit after tax (PAT) of Rs 54 crore for the June quarter FY25, compared to a Rs 89 crore loss a year ago. Revenue rose to Rs 2,172 crore from Rs 1,930 crore. EBITDA increased to Rs 97 crore from Rs 13 crore. The company cited growth in part truckload (PTL) and … Read more

Omaxe shares fell 5% on Friday due to a Securities and Exchange Board of India (Sebi) ban. Sebi has barred Omaxe, its Chairman Rohtas Goel, MD Mohit Goel, and three others from the securities market for two years for misrepresenting financials. The stock hit its lower circuit limits on both NSE and BSE, declining 15% … Read more

The National Stock Exchange (NSE) warned investors on Friday about an entity promising guaranteed returns on stock market investments. This notice followed complaints about Amit Lilhare, an authorized person of a registered stock broker, who was offering assured returns and collecting commission in personal bank accounts. The NSE is taking disciplinary actions against this trading … Read more

Sebi Chairperson Madhabi Puri Buch announced on Friday that the regulator is developing a new system to speed up IPO approvals. The system will feature a simple template for companies and an AI tool for faster document review, expected by December. The new process aims to cut approval times from 42 days to 23 days … Read more

Alembic Pharmaceuticals announced it received approval from the USFDA to market Nelarabine Injection, a generic cancer treatment drug. The estimated market size for Nelarabine Injection is USD 23 million for the twelve months ending March 2024. Alembic now has 211 ANDA approvals. Shares rose 1.93% to Rs 1,235 on NSE. This product, equivalent to Sandoz … Read more

Shares of Zomato soared 19% to a record high of Rs 278.70 on Friday after the company reported a significant increase in profit after tax (PAT) for the June quarter. Zomato’s PAT jumped to Rs 253 crore, up from Rs 2 crore in the same period last year. Following this impressive performance, brokerages like CLSA … Read more

Infosys reported on Thursday that Karnataka state authorities have withdrawn the Rs 32,403 crore GST demand ‘pre-show cause’ notice and directed it to respond further to the Directorate General of GST Intelligence (DGGI). This notice, related to services from Infosys’s overseas branches for July 2017 to March 2022, was received on Wednesday. Infosys maintains that … Read more

Road Transport and Highways Minister Nitin Gadkari announced plans to award road contracts worth Rs 3 lakh crore within three months and aim for Rs 5 lakh crore by the end of the financial year. Due to the Lok Sabha elections and the model code of conduct, initial project awards were slow. The National Highways … Read more